Impaired central stress-induced release of noradrenaline in rats with heart failure: A microdialysis study

Neuroscience

Volumn 114, Issue 3, 2002, Pages 591-599

  Arabia, A M ^a,b   Catapano, L ^a   Storini, C ^a   Perego, C ^a   De Luigi, A ^a   Head, G A ^b   De Simoni, M G ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Corticosterone; Hypothalamo pituitary adrenocortical; Myocardial infarction; Norepinephrine; Paraventricular nucleus; Stress

Indexed keywords

CORTICOSTERONE; NORADRENALIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HEART FAILURE; HEART FUNCTION; HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

ANIMALS; CORTICOSTERONE; HEART FAILURE, CONGESTIVE; IMMOBILIZATION; MALE; MICRODIALYSIS; NOREPINEPHRINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; STRESS;

EID: 0037063707     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00337-8     Document Type: Article

References (43)

1. Anversa P., Beghi C., Kikkawa Y., Olivetti G. Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy. Am. J. Pathol. 118:1985;484-492.
2. Anversa P., Loud A.V., Levicky V., Guideri G. Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy. Am. J. Physiol. 248:1985;H876-H882.
3. Anversa P., Loud A.V., Levicky V., Guideri G. Left ventricular failure induced by myocardial infarction. II. Tissue morphometry. Am. J. Physiol. 248:1985;H883-H889.
4. Basu S., Sinha S.K., Shao Q., Ganguly P.K., Dhalla N.S. Neuropeptide Y modulation of sympathetic activity in myocardial infarction. J. Am. Coll. Cardiol. 27:1996;1796-1803.
5. Borkowski K.R., Finch L. Cardiovascular changes in anaesthetised rats after the intra-hypothalamic administration of adrenaline. Clin. Exp. Hypertens. 1:1978;279-291.
6. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., Simon A.B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311:1984;819-823.
7. Coote J.H. Cardiovascular function of the paraventricular nucleus of the hypothalamus. Biol. Signals. 4:1995;142-149.
8. Cunningham E.T. Jr., Bohn M.C., Sawchencho P.E. Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J. Comp. Neurol. 292:1990;651-667.
9. Dampney R.A.L. Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev. 74:1994;323-364.
10. Deering J., Coote J.H. Paraventricular neurones elicit a volume expansion-like change of activity in sympathetic nerves to the heart and kidney in the rabbit. Exp. Physiol. 85:2000;177-186.
11. DiBona G.F., Sawin L.L., Jones S.Y. Characteristics of renal sympathetic nerve activity in sodium-retaining disorders. Am. J. Physiol. 271:1996;R295-R302.
12. Ferguson D.W., Berg W.J., Sanders J.S. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J. Am. Coll. Cardiol. 16:1990;1125-1134.
13. Ferguson A.V., Latchford K.J. Local circuitry regulates the excitability of rat neurohypophysial neurones. Exp. Physiol. 85:2000;153S-161S.
14. Francis G.S., Goldsmith S.R., Ziesche S., Nakajima H., Cohn J.N. Relative attenuation of sympathetic drive during exercise in patients with congestive heart failure. J. Am. Coll. Cardiol. 5:1985;832-839.
15. Fuller R.W. The involvement of serotonin in regulation of pituitary-adrenocortical function. Front. Neuroendocrinol. 13:1992;250-270.
16. Goldman S., Raya T.E. Rat infarct model of myocardial infarction and heart failure. J. Card. Fail. 1:1995;169-177.
17. Hasking E., Jennings G., Burton D., Korner P.I. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence for increased overall and cardiorenal sympathetic nervous activity. Circulation. 73:1986;615-621.
18. Head G.A., Badoer E., Korner P.I. Cardiovascular role of A1 catecholaminergic neurons in the rabbit. Effect of chronic lesions on responses to methyldopa, clonidine and 6-OHDA induced transmitter release. Brain Res. 412:1987;18-28.
19. Kannan H., Hayashida Y., Yamashita H. Increase in sympathetic outflow by paraventricular nucleus stimulation in awake rats. Am. J. Physiol. 256:1989;R1325-R1330.
20. Kaye D.M., Lambert G.W., Lefkovits J., Morris M., Jennings G., Esler M.D. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J. Am. Coll. Cardiol. 23:1994;570-578.
21. Kenney M.J., Musch T.I., Weiss M.L. Renal sympathetic nerve regulation to heating is altered in rats with heart failure. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H2868-H2875.
22. Leenen F.H., Huang B.S., Yu H., Yuan B. Brain 'ouabain' mediates sympathetic hyperactivity in congestive heart failure. Circ. Res. 77:1995;993-1000.
23. Leimbach W.N. Jr., Wallin B.G., Victor R.G., Aylward P.E., Sundlof G., Mark A.L. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 73:1986;913-919.
24. Linthorst A.C., Flachskamm C., Holsboer F., Reul J.M. Intraperitoneal administration of bacterial endotoxin enhances noradrenergic neurotransmission in the rat preoptic area: relationship with body temperature and hypothalamic-pituitary-adrenocortical axis activity. Eur. J. Neurosci. 7:1995;2418-2430.
25. Liposits Z., Sherman D., Phelix C., Paull W.K. A combined light and electron microscopic immunocytochemical method for the simultaneous localization of multiple tissue antigens. Tyrosine hydroxylase immunoreactive innervation of corticotropin releasing factor synthesizing neurons in the paraventricular nucleus of the rat. Histochemistry. 85:1986;95-106.
26. Morita H., Zhou M., Foecking M.F., Gomez-Sanchez E.P., Cozza E.N., Gomez-Sanchez C.E. 11 beta-Hydroxysteroid dehydrogenase type 2 complementary deoxyribonucleic acid stably transfected into Chinese hamster ovary cells: specific inhibition by 11 alpha-hydroxyprogesterone. Endocrinology. 137:1996;2308-2314.
27. Pacak K., Palkovits M., Kvetnansky R., Kopin I.J., Goldstein D.S. Stress-induced norepinephrine release in the paraventricular nucleus of rats with brainstem hemisections: a microdialysis study. Neuroendocrinology. 58:1993;196-201.
28. Patel K.P., Zhang K., Carmines P.K. Norepinephrine turnover in peripheral tissues of rats with heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;556-562.
29. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., Braunwald E. Myocardial infarct size and ventricular function in rats. Circ. Res. 44:1979;503-512.
30. Plotsky P.M. Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology. 121:1987;924-930.
31. Plotsky P.M., Cunningham E.T. Jr., Widmaier E.P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr. Rev. 10:1989;437-458.
32. Porter J.P., Brody M.J. Neural projections from paraventricular nucleus that subserve vasomotor functions. Am. J. Physiol. 248:1985;R271-R281.
33. Robinson T.E., Whishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 450:1988;209-224.
34. Rocchetti M., De Nicolao G. CURT: a randomization test for statistical comparison between experimental curves. Comput. Methods Programs Biomed. 31:1990;207-213.
35. Sharma A., Coats A.J., Anker S.D. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. Int. J. Cardiol. 72:2000;175-186.
36. Sole M.J., Benedict C.R., Versteeg D.H., de Kloet E.R. Digitoxin therapy partially restores cardiac catecholamine and brain serotonin metabolism in congestive heart failure. J. Mol. Cell Cardiol. 17:1985;1055-1063.
37. Swedberg K., Bergh C.H., Dickstein K., McNay J., Steinberg M. The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure. Moxonidine Investigators. J. Am. Coll. Cardiol. 35:2000;398-404.
38. Terrazzino S., Perego C., De Simoni M.G. Noradrenaline release in hypothalamus and ACTH secretion induced by central interleukin-1beta. NeuroReport. 6:1995;2465-2468.
39. Terrazzino S., Perego C., Vetrugno G., De Simoni G. Basal and stress-induced release of noradrenaline in hypothalamus of spontaneously hypertensive rats at different ages. Brain Res. 668:1994;256-260.
40. Vahid-Ansari F., Leenen F.H. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am. J. Physiol. 275:1998;H2140-H2146.
41. Van Kerckhoven R., van Veen T.A.B., Boomsma F., Saxena P.R., Schoemaker R.G. Chronic administration of moxonidine suppresses sympathetic activation in a rat heart failure model. Eur. J. Pharmacol. 397:2000;113-120.
42. Vetrugno G.C., Laucher J., Perego C., Miranda E., De Simoni M., Tappaz M. Lack of glucocorticoids sustains the stress-induced release of noradrenaline in the anterior hypothalamus. Neuroendocrinology. 57:1993;835-842.
43. Yamaoka M., Yamaguchi S., Okuyama M., Tomoike H. Anti-inflammatory cytokine profile in human heart failure: behavior of interleukin-10 in association with tumor necrosis factor-alpha. Jpn. Circ. J. 63:1999;951-956.